Mastering the rare disease challenge
Orphan drugs are few and far between. Long awaited by patients and physicians it should be an easy job to market them. However, diagnosis comes before treatment and with more than 6,000 rare diseases prevalent in Europe alone, it is little surprising that physicians are vague on specifics. Clinicians have…
